{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:54:59Z","timestamp":1793253299308,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["CL-2022-07-002"],"award-info":[{"award-number":["CL-2022-07-002"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SGL030\\1029"],"award-info":[{"award-number":["SGL030\\1029"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Epilepsy Research Institute - Emerging Leader Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Valproate is highly effective at treating epilepsy and bipolar disorder. It faces prescribing restrictions in men due to concerns it causes testicular dysfunction and infertility. These mostly stem from animal models \u2013 the human evidence is limited and conflicting. We report the largest ever retrospective cohort study of infertility in men with epilepsy or bipolar disorder, using real-world healthcare data from TriNetX. 91,917 of the men are exposed to valproate, and 535,803 unexposed. Cohorts are propensity score matched for a comprehensive set of baseline covariates, and survival analysis is undertaken using Cox-proportional hazards models. No significant difference is seen between valproate-exposed and unexposed men across lifetime risks of infertility, testicular hypofunction, testicular atrophy, and a composite of low sperm concentration, motility, vitality, normal forms, and semen volume (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&gt;\u20090.05). Our findings do not support an association between valproate and infertility in men with epilepsy or bipolar disorder in real-world settings.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-63469-0","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T09:05:04Z","timestamp":1757927104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A retrospective cohort study of valproate and infertility in men with epilepsy or bipolar disorder using international health data"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-2944","authenticated-orcid":false,"given":"Gashirai K.","family":"Mbizvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Nancarrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Sagarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0447-5906","authenticated-orcid":false,"given":"Lance V.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-8640","authenticated-orcid":false,"given":"Michael T.","family":"Mbizvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"63469_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs, R. D., Surges, R., O\u2019Brien, T. J. & Sander, J. W. Epilepsy in adults. Lancet 393, 689\u2013701 (2019).","journal-title":"Lancet"},{"key":"63469_CR2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04160","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Li, Y., Pan, H. & Han, L. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. J. Glob. Health 13, 04160 (2023).","journal-title":"J. Glob. Health"},{"key":"63469_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","volume":"397","author":"A Marson","year":"2021","unstructured":"Marson, A. et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 397, 1375\u20131386 (2021).","journal-title":"Lancet"},{"key":"63469_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson, A. G. et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369, 1016\u20131026 (2007).","journal-title":"Lancet"},{"key":"63469_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.9758\/cpn.2022.20.3.403","volume":"20","author":"C Crapanzano","year":"2022","unstructured":"Crapanzano, C., Casolaro, I., Amendola, C. & Damiani, S. Lithium and valproate in bipolar disorder: from international evidence-based guidelines to clinical predictors. Clin. Psychopharmacol. Neurosci. 20, 403\u2013414 (2022).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"63469_CR6","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.7861\/clinmedicine.18-2-s1","volume":"18","author":"RH Thomas","year":"2018","unstructured":"Thomas, R. H. Valproate: life-saving, life-changing. Clin. Med (Lond.) 18, s1\u2013s8 (2018).","journal-title":"Clin. Med (Lond.)"},{"key":"63469_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/HRP.0000000000000292","volume":"29","author":"CS Yee","year":"2021","unstructured":"Yee, C. S. et al. Long-term treatment of bipolar disorder with valproate: updated systematic review and meta-analyses. Harv. Rev. Psychiatry 29, 188\u2013195 (2021).","journal-title":"Harv. Rev. Psychiatry"},{"key":"63469_CR8","unstructured":"Medicines and Healthcare products Regulatory Agency. Valproate: reminder of current Pregnancy Prevention Programme requirements; information on new safety measures to be introduced in the coming months. https:\/\/tinyurl.com\/z8v8bb8e (2022)."},{"key":"63469_CR9","unstructured":"Medicines and Pregnancy Registry. [MI] Medicines and Pregnancy Registry - Antiepileptic use in females aged 0 to 54 in England: April 2018 to September 2021.https:\/\/tinyurl.com\/2kpxjd8x (2022)."},{"key":"63469_CR10","doi-asserted-by":"publisher","unstructured":"Caroline E. D. et al. Use of sodium valproate and other anti-seizure medications in England and Wales during the COVID-19 pandemic: a population-level analysis of 60 million individuals. https:\/\/doi.org\/10.2139\/ssrn.4544777 (2023).","DOI":"10.2139\/ssrn.4544777"},{"key":"63469_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/ene.13610","volume":"25","author":"LJ Virta","year":"2018","unstructured":"Virta, L. J., Kalviainen, R., Villikka, K. & Keranen, T. Declining trend in valproate use in Finland among females of childbearing age in 2012-2016 - a nationwide registry-based outpatient study. Eur. J. Neurol. 25, 869\u2013874 (2018).","journal-title":"Eur. J. Neurol."},{"key":"63469_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/pds.5427","volume":"31","author":"JE Hughes","year":"2022","unstructured":"Hughes, J. E. et al. Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: a drug utilisation study using interrupted time series. Pharmacoepidemiol Drug Saf. 31, 661\u2013669 (2022).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"63469_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s40264-023-01314-3","volume":"46","author":"S Abtahi","year":"2023","unstructured":"Abtahi, S. et al. Impact of 2018 EU Risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an interrupted time series study. Drug Saf. 46, 689\u2013702 (2023).","journal-title":"Drug Saf."},{"key":"63469_CR14","unstructured":"Medicines and Healthcare products Regulatory Agency. National Patient Safety Alert: Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients (NatPSA\/2023\/013\/MHRA). https:\/\/tinyurl.com\/55j6cu8b (2023)."},{"key":"63469_CR15","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Valproate \u2013 reproductive risks. Guidance https:\/\/www.gov.uk\/guidance\/valproate-reproductive-risks (2025)."},{"key":"63469_CR16","unstructured":"Health Sciences Authority. Epilim\u00ae (Valproate) - Risk of neurodevelopmental disorders, including autism spectrum disorders, in children after paternal exposure. https:\/\/tinyurl.com\/4xyp2hdd (2023)."},{"key":"63469_CR17","unstructured":"New Zealand Medicines and Medical Devices Authority. Sodium valproate (Epilim) use in people who can father children: important new safety information. https:\/\/www.medsafe.govt.nz\/safety\/Alerts\/Sodium_valproate_Epilim_use_in_people_who_can_father_children.asp (2023)."},{"key":"63469_CR18","unstructured":"Swanborough N. Sanofi reports issues around the safety study into valproate. https:\/\/epilepsysociety.org.uk\/news\/valproate-safety-study-concerns (2023)."},{"key":"63469_CR19","doi-asserted-by":"publisher","unstructured":"Angus-Leppan, H. et al. New valproate regulations, informed choice and seizure risk. J Neurol, https:\/\/doi.org\/10.1007\/s00415-024-12436-8 (2024).","DOI":"10.1007\/s00415-024-12436-8"},{"key":"63469_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106835","volume":"103","author":"LV Watkins","year":"2020","unstructured":"Watkins, L. V. & Angus-Leppan, H. Valproate, sexual health, and men: a narrative review. Epilepsy Behav. 103, 106835 (2020).","journal-title":"Epilepsy Behav."},{"key":"63469_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/seiz.2001.0545","volume":"10","author":"L Sveberg Roste","year":"2001","unstructured":"Sveberg Roste, L. et al. Morphological changes in the testis after long-term valproate treatment in male Wistar rats. Seizure 10, 559\u2013565 (2001).","journal-title":"Seizure"},{"key":"63469_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/0253-7613.64503","volume":"42","author":"L Bairy","year":"2010","unstructured":"Bairy, L., Paul, V. & Rao, Y. Reproductive toxicity of sodium valproate in male rats. Indian J. Pharm. 42, 90\u201394 (2010).","journal-title":"Indian J. Pharm."},{"key":"63469_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0300-483X(90)90038-I","volume":"63","author":"RM Walker","year":"1990","unstructured":"Walker, R. M., Smith, G. S., Barsoum, N. J. & Macallum, G. E. Preclinical toxicology of the anticonvulsant calcium valproate. Toxicology 63, 137\u2013155 (1990).","journal-title":"Toxicology"},{"key":"63469_CR24","unstructured":"OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. https:\/\/www.cebm.net\/wp-content\/uploads\/2014\/06\/CEBM-Levels-of-Evidence-2.1.pdf\u00a0(2011)."},{"key":"63469_CR25","first-page":"223","volume":"23","author":"E Aldemir","year":"2012","unstructured":"Aldemir, E. et al. Valproate-associated reproductive hormone abnormalities: do bipolar men have the same risk as epileptic men?. Turk. Psikiyatr. Derg. 23, 223\u2013227 (2012).","journal-title":"Turk. Psikiyatr. Derg."},{"key":"63469_CR26","first-page":"145","volume":"23","author":"E Aldemir","year":"2012","unstructured":"Aldemir, E. et al. Abnormal semen parameters in bipolar men treated with valproate. Turk. Psikiyatr. Derg. 23, 145\u2013146 (2012).","journal-title":"Turk. Psikiyatr. Derg."},{"key":"63469_CR27","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/humrep\/del194","volume":"21","author":"M Artama","year":"2006","unstructured":"Artama, M., Isojarvi, J. I. & Auvinen, A. Antiepileptic drug use and birth rate in patients with epilepsy-a population-based cohort study in Finland. Hum. Reprod. 21, 2290\u20132295 (2006).","journal-title":"Hum. Reprod."},{"key":"63469_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1528-1157.1999.tb02075.x","volume":"40","author":"S Duncan","year":"1999","unstructured":"Duncan, S., Blacklaw, J., Beastall, G. H. & Brodie, M. J. Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia 40, 197\u2013204 (1999).","journal-title":"Epilepsia"},{"key":"63469_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6624101","volume":"2021","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. A comparative study of the effects of valproate and oxcarbazepine on sexual function, sperm quality, and sex hormones in males with epilepsy. Biomed. Res Int 2021, 6624101 (2021).","journal-title":"Biomed. Res Int"},{"key":"63469_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jocn.2014.08.029","volume":"22","author":"SA Hamed","year":"2015","unstructured":"Hamed, S. A. et al. Seminal fluid analysis and testicular volume in adults with epilepsy receiving valproate. J. Clin. Neurosci. 22, 508\u2013512 (2015).","journal-title":"J. Clin. Neurosci."},{"key":"63469_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/00365590500252688","volume":"39","author":"T Hayashi","year":"2005","unstructured":"Hayashi, T. et al. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin. Scand. J. Urol. Nephrol. 39, 431\u2013432 (2005).","journal-title":"Scand. J. Urol. Nephrol."},{"key":"63469_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1212\/01.WNL.0000098936.46730.64","volume":"62","author":"JI Isojarvi","year":"2004","unstructured":"Isojarvi, J. I. et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 62, 247\u2013253 (2004).","journal-title":"Neurology"},{"key":"63469_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/ane.13311","volume":"142","author":"S Markoula","year":"2020","unstructured":"Markoula, S., Siarava, E., Kostoulas, C., Zikopoulos, A. & Georgiou, I. An open study of valproate in subfertile men with epilepsy. Acta Neurol. Scand. 142, 317\u2013322 (2020).","journal-title":"Acta Neurol. Scand."},{"key":"63469_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.0013-9580.2004.04604.x","volume":"45","author":"K Mikkonen","year":"2004","unstructured":"Mikkonen, K. et al. Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy. Epilepsia 45, 769\u2013776 (2004).","journal-title":"Epilepsia"},{"key":"63469_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/ane.12892","volume":"137","author":"L Ocek","year":"2018","unstructured":"Ocek, L. et al. Evaluation of sex hormones and sperm parameters in male epileptic patients. Acta Neurol. Scand. 137, 409\u2013416 (2018).","journal-title":"Acta Neurol. Scand."},{"key":"63469_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/WNL.56.1.31","volume":"56","author":"J Rattya","year":"2001","unstructured":"Rattya, J. et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 56, 31\u201336 (2001).","journal-title":"Neurology"},{"key":"63469_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1468-1331.2003.00615.x","volume":"10","author":"LS Roste","year":"2003","unstructured":"Roste, L. S. et al. Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. Eur. J. Neurol. 10, 501\u2013506 (2003).","journal-title":"Eur. J. Neurol."},{"key":"63469_CR38","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jocn.2012.11.028","volume":"20","author":"X Xiaotian","year":"2013","unstructured":"Xiaotian, X. et al. Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy. J. Clin. Neurosci. 20, 1492\u20131497 (2013).","journal-title":"J. Clin. Neurosci."},{"key":"63469_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1528-1157.1999.tb00752.x","volume":"40","author":"MS Yerby","year":"1999","unstructured":"Yerby, M. S. & McCoy, G. B. Male infertility: possible association with valproate exposure. Epilepsia 40, 520\u2013521 (1999).","journal-title":"Epilepsia"},{"key":"63469_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0896-6974(94)90053-1","volume":"7","author":"VL Curtis","year":"1994","unstructured":"Curtis, V. L., Oelberg, D. G. & Willmore, L. J. Infertility secondary to valproate. J. Epilepsy 7, 259\u2013261 (1994).","journal-title":"J. Epilepsy"},{"key":"63469_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2021.100446","volume":"16","author":"E Tallon","year":"2021","unstructured":"Tallon, E., O\u2019Donovan, L. & Delanty, N. Reversible male infertility with valproate use: a review of the literature. Epilepsy Behav. Rep. 16, 100446 (2021).","journal-title":"Epilepsy Behav. Rep."},{"key":"63469_CR42","first-page":"164","volume":"14","author":"H Kose-Ozlece","year":"2015","unstructured":"Kose-Ozlece, H., Ilik, F., Cecen, K., Huseyinoglu, N. & Serim, A. Alterations in semen parameters in men with epilepsy treated with valproate. Iran. J. Neurol. 14, 164\u2013167 (2015).","journal-title":"Iran. J. Neurol."},{"key":"63469_CR43","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.0000000000000152","volume":"34","author":"EL Fu","year":"2023","unstructured":"Fu, E. L. Target trial emulation to improve causal inference from observational data: what, why, and how?. J. Am. Soc. Nephrol. 34, 1305\u20131314 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63469_CR44","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hernan","year":"2022","unstructured":"Hernan, M. A., Wang, W. & Leaf, D. E. Target trial emulation: a framework for causal inference from observational data. JAMA 328, 2446\u20132447 (2022).","journal-title":"JAMA"},{"key":"63469_CR45","unstructured":"Herna\u0301n, M. A. & Robins, J. M. Causal inference: what if. (Taylor and Francis, 2024)."},{"key":"63469_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1528-1157.1986.tb03605.x","volume":"27","author":"MP Webber","year":"1986","unstructured":"Webber, M. P., Hauser, W. A., Ottman, R. & Annegers, J. F. Fertility in persons with epilepsy: 1935-1974. Epilepsia 27, 746\u2013752 (1986).","journal-title":"Epilepsia"},{"key":"63469_CR47","unstructured":"TriNetX. Welcome to the world\u2019s largest, living ecosystem of real-world data and evidence for the life sciences and healthcare industries. Global data for global health. www.trinetx.com (2023)."},{"key":"63469_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk, M. B. et al. A global federated real-world data and analytics platform for research. JAMIA Open 6, ooad035 (2023).","journal-title":"JAMIA Open"},{"key":"63469_CR49","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/epi.16547","volume":"61","author":"GK Mbizvo","year":"2020","unstructured":"Mbizvo, G. K. et al. The accuracy of using administrative healthcare data to identify epilepsy cases: a systematic review of validation studies. Epilepsia 61, 1319\u20131335 (2020).","journal-title":"Epilepsia"},{"key":"63469_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2020.106462","volume":"167","author":"GK Mbizvo","year":"2020","unstructured":"Mbizvo, G. K., Schnier, C., Simpson, C. R., Duncan, S. E. & Chin, R. F. M. Validating the accuracy of administrative healthcare data identifying epilepsy in deceased adults: a Scottish data linkage study. Epilepsy Res. 167, 106462 (2020).","journal-title":"Epilepsy Res"},{"key":"63469_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2023.107275","volume":"199","author":"GK Mbizvo","year":"2024","unstructured":"Mbizvo, G. K., Simpson, C. R., Duncan, S. E., Chin, R. F. M. & Larner, A. J. Critical success index or F measure to validate the accuracy of administrative healthcare data identifying epilepsy in deceased adults in Scotland. Epilepsy Res. 199, 107275 (2024).","journal-title":"Epilepsy Res"},{"key":"63469_CR52","doi-asserted-by":"publisher","unstructured":"Mbizvo, G. K. et al. Using Critical Success Index or Gilbert Skill score as composite measures of positive predictive value and sensitivity in diagnostic accuracy studies: weather forecasting informing epilepsy research. Epilepsia, https:\/\/doi.org\/10.1111\/epi.17537 (2023).","DOI":"10.1111\/epi.17537"},{"key":"63469_CR53","unstructured":"National Centre for Health Statistics. ICD-10-CM. Centers for Disease Control and Prevention (CDC). https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html (2024)."},{"key":"63469_CR54","unstructured":"ICDLIST. 2025 ICD-10-CM Diagnosis Code N46.8. https:\/\/icdlist.com\/icd-10\/N46.8 (2024)."},{"key":"63469_CR55","unstructured":"ICDLIST. 2025 ICD-10-CM Diagnosis Code N46.9. https:\/\/icdlist.com\/icd-10\/N46.9 (2024)."},{"key":"63469_CR56","unstructured":"ICDLIST. 2025 ICD-10-CM Diagnosis Code E29.1. https:\/\/icdlist.com\/icd-10\/E29.1 (2024)."},{"key":"63469_CR57","unstructured":"ICDLIST. 2025 ICD-10-CM Diagnosis Code N50.0. https:\/\/icdlist.com\/icd-10\/N50.0 (2024)."},{"key":"63469_CR58","doi-asserted-by":"publisher","unstructured":"Boitrelle, F. et al. The Sixth Edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life (Basel) 11, https:\/\/doi.org\/10.3390\/life11121368 (2021).","DOI":"10.3390\/life11121368"},{"key":"63469_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.fertnstert.2021.11.037","volume":"117","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Evolution of the WHO \u201cSemen\u201d processing manual from the first (1980) to the sixth edition (2021). Fertil. Steril. 117, 237\u2013245 (2022).","journal-title":"Fertil. Steril."},{"key":"63469_CR60","unstructured":"World Health Organization. WHO laboratory manual for the examination and processing of human semen, (World Health Organization, Geneva, 2021)."},{"key":"63469_CR61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/ckj\/sfaa242","volume":"14","author":"EL Fu","year":"2021","unstructured":"Fu, E. L. et al. Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them. Clin. Kidney J. 14, 1317\u20131326 (2021).","journal-title":"Clin. Kidney J."},{"key":"63469_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jclinepi.2022.05.021","volume":"149","author":"A van Zwieten","year":"2022","unstructured":"van Zwieten, A. et al. Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer. J. Clin. Epidemiol. 149, 127\u2013136 (2022).","journal-title":"J. Clin. Epidemiol."},{"key":"63469_CR63","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ije\/dyaa213","volume":"50","author":"PWG Tennant","year":"2021","unstructured":"Tennant, P. W. G. et al. Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations. Int J. Epidemiol. 50, 620\u2013632 (2021).","journal-title":"Int J. Epidemiol."},{"key":"63469_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2018.12.10","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Kim, H. J., Lonjon, G. & Zhu, Y. & written on behalf of, A. M. E. B.-D. C. T. C. G. Balance diagnostics after propensity score matching. Ann. Transl. Med. 7, 16 (2019).","journal-title":"Ann. Transl. Med"},{"key":"63469_CR65","unstructured":"Sizar, O., Leslie, S. W. & Schwartz, J. in StatPearls (StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC., 2024)."},{"key":"63469_CR66","doi-asserted-by":"publisher","unstructured":"Markousis-Mavrogenis, G. et al. The emerging role of combined brain\/heart magnetic resonance imaging for the evaluation of brain\/heart interaction in heart failure. J Clin Med. 11, https:\/\/doi.org\/10.3390\/jcm11144009 (2022).","DOI":"10.3390\/jcm11144009"},{"key":"63469_CR67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/humrep\/deae292","volume":"40","author":"Y Liang","year":"2025","unstructured":"Liang, Y. et al. Global, regional, and national prevalence and trends of infertility among individuals of reproductive age (15\u201349 years) from 1990 to 2021, with projections to 2040. Hum. Reprod. 40, 529\u2013544 (2025).","journal-title":"Hum. Reprod."},{"key":"63469_CR68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/00926230390195524","volume":"29","author":"KP Rosenberg","year":"2003","unstructured":"Rosenberg, K. P., Bleiberg, K. L., Koscis, J. & Gross, C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J. Sex. Marital Ther. 29, 289\u2013296 (2003).","journal-title":"J. Sex. Marital Ther."},{"key":"63469_CR69","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","volume":"5","author":"JW Chen","year":"2006","unstructured":"Chen, J. W. & Wasterlain, C. G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 5, 246\u2013256 (2006).","journal-title":"Lancet Neurol."},{"key":"63469_CR70","doi-asserted-by":"publisher","unstructured":"Mbizvo, G. K., Bucci, T., Lip, G. Y. H. & Marson, A. G. Morbidity and mortality risks associated with valproate withdrawal in young men and women with epilepsy. Brain https:\/\/doi.org\/10.1093\/brain\/awae128 (2024).","DOI":"10.1093\/brain\/awae128"},{"key":"63469_CR71","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v14.i1.90590","volume":"14","author":"MYQ Liau","year":"2024","unstructured":"Liau, M. Y. Q., Toh, E. Q., Muhamed, S., Selvakumar, S. V. & Shelat, V. G. Can propensity score matching replace randomized controlled trials?. World J. Methodol. 14, 90590 (2024).","journal-title":"World J. Methodol."},{"key":"63469_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40360-024-00791-1","volume":"25","author":"MA Asghar","year":"2024","unstructured":"Asghar, M. A. et al. Understanding the impact of valproate on male fertility: insights from preclinical and clinical meta-analysis. BMC Pharm. Toxicol. 25, 69 (2024).","journal-title":"BMC Pharm. Toxicol."},{"key":"63469_CR73","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins, J. M., Hernan, M. A. & Brumback, B. Marginal structural models and causal inference in epidemiology. Epidemiology 11, 550\u2013560 (2000).","journal-title":"Epidemiology"},{"key":"63469_CR74","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ede.0000222409.00878.37","volume":"17","author":"MA Hernan","year":"2006","unstructured":"Hernan, M. A. & Robins, J. M. Instruments for causal inference: an epidemiologist\u2019s dream?. Epidemiology 17, 360\u2013372 (2006).","journal-title":"Epidemiology"},{"key":"63469_CR75","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.psychres.2017.11.004","volume":"259","author":"E Zander","year":"2018","unstructured":"Zander, E. et al. Validity of routine clinical diagnoses in acute psychiatric inpatients. Psychiatry Res. 259, 482\u2013487 (2018).","journal-title":"Psychiatry Res"},{"key":"63469_CR76","unstructured":"Medicines and Healthcare products Regulatory Agency. Patient Guide: what you need to know about valproate. https:\/\/mhra-gov.filecamp.com\/s\/i\/Zw7qR7wEy1YKeIEf (2023)."},{"key":"63469_CR77","unstructured":"Arkell R. Women with epilepsy need choice, not diktats, when it comes to sodium valproate. The Pharmaceutical Journal https:\/\/tinyurl.com\/yckd3zfs (2023)."},{"key":"63469_CR78","unstructured":"CPRD. Clinical Practice Research Datalink. National Institute for Health and Care Research. https:\/\/cprd.com (2023)."},{"key":"63469_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-017-0714-7","volume":"18","author":"YS Khandwala","year":"2017","unstructured":"Khandwala, Y. S., Zhang, C. A., Li, S., Cullen, M. R. & Eisenberg, M. L. Validity of claims data for the identification of male infertility. Curr. Urol. Rep. 18, 68 (2017).","journal-title":"Curr. Urol. Rep."},{"key":"63469_CR80","unstructured":"TriNetX Engineering. Function propensity_score. trinetx 0.1.0 Functions. https:\/\/lucid.trinetx.com\/r\/v1.0\/reference\/propensity_score.html (2025)."},{"key":"63469_CR81","unstructured":"TriNetX Engineering. Function propensity_score_matching. trinetx 0.1.0 Functions. https:\/\/lucid.trinetx.com\/r\/v1.0\/reference\/propensity_score_matching.html#details (2025)."},{"key":"63469_CR82","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4097\/kjae.2017.70.2.144","volume":"70","author":"SG Kwak","year":"2017","unstructured":"Kwak, S. G. & Kim, J. H. Central limit theorem: the cornerstone of modern statistics. Korean J. Anesthesiol. 70, 144\u2013156 (2017).","journal-title":"Korean J. Anesthesiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63469-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63469-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63469-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T09:05:21Z","timestamp":1757927121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63469-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63469"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63469-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.G.M. declares i) a UCB Pharma grant paid to University of Liverpool for the National Audit of Seizure Management in Hospitals (NASH) study, which is unrelated to the submitted work; ii) an Angelini grant to be paid to University of Liverpool as co-applicant for A multi-method PRoject to maximise efficient and equitable pathways tO suPport from a rEgional epiLepsy centre (PROPEL), which is unrelated to the submitted work; iii) Honoraria paid to University of Liverpool for lectures unrelated to the submitted work given at educational events sponsored by Sanofi, Eiasi, and GSK; iii) Support from Angelini for attendance unrelated to the submitted work at the 2024 International League Against Epilepsy (ILAE) congress. G.K.M. declares an Angelini grant paid to the University of Liverpool as co-applicant on the PROPEL study, which is unrelated to the submitted work; ii) Honoraria paid to the University of Liverpool for delivering a lecture at an educational event sponsored by Angelini, which was unrelated to the submitted work. G.Y.H.L. is a consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, and Anthos, which is unrelated to the submitted work. No fees are received personally. G.Y.H.L. is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No. 899871, which is unrelated to the submitted work. T.S. is an employee of TriNetX, which routinely provides data for research studies, including the data used in this study. The involvement of T.S. as a co-author reflects her technical assistance as a data analyst and does not imply any compensation or influence from TriNetX on this study. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8221"}}